Positive Results of Phase II Clinical Study for the Treatment of Sialorrhea Presented at Parkinson’s Disease Congress

Newton, Massachusetts – December 10, 2010. NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces the presentation of clinical trial results with NH004 for the treatment of sialorrhea (uncontrolled drooling) in Parkinson’s disease patients. The presentation today at the International Congress on Mental…